ACLX
Price
$53.65
Change
+$0.86 (+1.63%)
Updated
May 17, 2:57 PM EST
87 days until earnings call
SLDB
Price
$8.95
Change
-$0.35 (-3.76%)
Updated
May 17, 6:59 PM EST
Ad is loading...

ACLX vs SLDB

Header iconACLX vs SLDB Comparison
Open Charts ACLX vs SLDBBanner chart's image
Arcellx
Price$53.65
Change+$0.86 (+1.63%)
Volume$3.62K
CapitalizationN/A
Solid Biosciences
Price$8.95
Change-$0.35 (-3.76%)
Volume$135.42K
CapitalizationN/A
View a ticker or compare two or three
ACLX vs SLDB Comparison Chart

Loading...

ACLXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
SLDBDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ACLX vs. SLDB commentary
May 17, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACLX is a Buy and SLDB is a Hold.

COMPARISON
Comparison
May 17, 2024
Stock price -- (ACLX: $52.79 vs. SLDB: $9.30)
Brand notoriety: ACLX and SLDB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACLX: 116% vs. SLDB: 76%
Market capitalization -- ACLX: $2.77B vs. SLDB: $366.87M
ACLX [@Biotechnology] is valued at $2.77B. SLDB’s [@Biotechnology] market capitalization is $366.87M. The market cap for tickers in the [@Biotechnology] industry ranges from $592.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.75B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACLX’s FA Score shows that 0 FA rating(s) are green whileSLDB’s FA Score has 1 green FA rating(s).

  • ACLX’s FA Score: 0 green, 5 red.
  • SLDB’s FA Score: 1 green, 4 red.
According to our system of comparison, SLDB is a better buy in the long-term than ACLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACLX’s TA Score shows that 4 TA indicator(s) are bullish while SLDB’s TA Score has 4 bullish TA indicator(s).

  • ACLX’s TA Score: 4 bullish, 3 bearish.
  • SLDB’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ACLX is a better buy in the short-term than SLDB.

Price Growth

ACLX (@Biotechnology) experienced а +0.11% price change this week, while SLDB (@Biotechnology) price change was -10.06% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.81%. For the same industry, the average monthly price growth was +4.40%, and the average quarterly price growth was +61.33%.

Reported Earning Dates

ACLX is expected to report earnings on Aug 12, 2024.

SLDB is expected to report earnings on May 11, 2023.

Industries' Descriptions

@Biotechnology (+2.81% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ACLX with price predictions.
OPEN
A.I.dvisor published
a Summary for SLDB with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
ACLX($2.77B) has a higher market cap than SLDB($367M). SLDB YTD gains are higher at: 51.466 vs. ACLX (-4.883).
ACLXSLDBACLX / SLDB
Capitalization2.77B367M754%
EBITDAN/AN/A-
Gain YTD-4.88351.466-9%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
SLDB: Fundamental Ratings
SLDB
OUTLOOK RATING
1..100
4
VALUATION
overvalued / fair valued / undervalued
1..100
38
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
3
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACLXSLDB
RSI
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
73%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 8 days ago
84%
Declines
ODDS (%)
Bearish Trend 10 days ago
77%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
ACLXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
SLDBDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CAIFX69.17-0.06
-0.09%
American Funds Capital Income Bldr F2
SENCX64.74-0.11
-0.17%
Touchstone Large Cap Focused A
HMVSX18.68-0.07
-0.37%
Hartford MidCap Value R4
ETLCX13.64-0.07
-0.51%
Eventide Large Cap Focus C
LICCX15.47-0.09
-0.58%
Lord Abbett International Equity C

ACLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACLX has been loosely correlated with ALLO. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ACLX jumps, then ALLO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACLX
1D Price
Change %
ACLX100%
+2.07%
ALLO - ACLX
44%
Loosely correlated
+1.01%
NTLA - ACLX
43%
Loosely correlated
-0.19%
VRDN - ACLX
42%
Loosely correlated
+2.52%
BEAM - ACLX
42%
Loosely correlated
-1.33%
XNCR - ACLX
41%
Loosely correlated
+5.50%
More

SLDB and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLDB has been loosely correlated with ACLX. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if SLDB jumps, then ACLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLDB
1D Price
Change %
SLDB100%
-4.02%
ACLX - SLDB
40%
Loosely correlated
+2.07%
MOLN - SLDB
35%
Loosely correlated
+4.31%
GLUE - SLDB
33%
Loosely correlated
-0.19%
VCEL - SLDB
30%
Poorly correlated
-3.64%
AVRO - SLDB
30%
Poorly correlated
+1.46%
More